Verna McErlane

Verna McErlane

Verna McErlane is currently Director of Commercial Operations, International at Sistemic Ltd.  Shegained her PhD in the area of pre-clinical cancer drug development and spent time working at the Gray Cancer Institute, London where she was involved with the formation of SPEAR Therapeutics Ltd prior to moving to the University of Dundee, Scotland to pursue evaluation of prodrug anticancer strategies. Subsequently, she was chosen to take part in the Saltire Foundation Fellowship program, 2009 where she moved to Boston and attended Babson College, before working with Genzyme (HQ) in International; New business initiatives, followed by an international market development position with Axis-Shield in Dundee, Scotland. She was also the recipient of the Galen Pharmaceutical Prize in 1999.